Abrdn World Healthcare Fund (THW) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$9.7M

Revenue (quarter)

$5.1M

Revenue growth (year over year)

−20.99%

Gross profit (trailing twelve months)

—

Gross margin

—

Net income (trailing twelve months)

$85.7M

Net income (quarter)

−$4.1M

Net income growth (year over year)

+88.03%

Net margin

885.44%

Return on equity

18.51%

EPS (trailing twelve months)

$2.14

Book value per share

$11.92

P/E (trailing twelve months)

5.62

Price to book

1.00

Debt to assets

20.22%

Payout ratio

98.99%

Dividend yield

11.75%

Company profile

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

• Is Abrdn World Healthcare Fund (THW) profitable?

  Yes. Abrdn World Healthcare Fund earned $85.7M in net income over the trailing twelve months, a net margin of 885.44%.

• How much revenue does Abrdn World Healthcare Fund (THW) make?

  Abrdn World Healthcare Fund generated $9.7M in revenue over the trailing twelve months, down 20.99% year over year.

• What is THW's P/E ratio?

  Abrdn World Healthcare Fund trades at 5.6 times trailing twelve-month earnings, on an EPS of $2.14.

• How do I buy stock in Abrdn World Healthcare Fund (THW)?

  THW trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.